Dr. Michael W. Cieslinski, MD

Dr. Cieslinski practices at Bon Secours Southern Virginia Medical Center in Emporia, Virginia, part of Bon Secours Mercy Health.

Dr. Cieslinski's NPI, 1093135196, was assigned on April 16, 2014. Dr. Cieslinski holds Virginia license 0101261661.

Dr. Cieslinski's primary practice is Bon Secours Southern Virginia Medical Center, at 727 North Main Street, Emporia, VA 23847 in Emporia City. The practice phone is (434) 348-4400.

Dr. Cieslinski's primary practice is Bon Secours Southern Virginia Medical Center in Emporia, Virginia, part of Bon Secours Mercy Health. Dr. Cieslinski is also affiliated with Bon Secours Southside Medical Center. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Cieslinski to 1 more hospital and 6 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cieslinski practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Cieslinski's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Cieslinski's licenses on file in 2 states: Virginia and North Carolina.

CMS data shows 340 Medicare services from Dr. Cieslinski across 4 procedure codes in 2024, for 313 Medicare patients. Medicare paid $38,875 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 313 Medicare patients who saw Dr. Cieslinski in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cieslinski's median patient age at 45, with 61% women.

In 2024, Dr. Cieslinski wrote 693 Medicare Part D claims for 328 patients. 94% of them were for generic drugs. CMS names the drug for 471 of them, across 17 drugs with 11 or more claims each, at $2,840 in total drug cost. In 2023, CMS named 344 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Cieslinski for performance year 2024, reported through an alternative payment model (APM). Dr. Cieslinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Cieslinski from 5 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $53.